Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

New medications could improve treatment for severe alopecia areata in Australia.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

5α-reduced neurosteroids may help regulate glial cell differentiation.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

Blocking YAP/TAZ could be a new way to treat skin cancer.

New treatments for skin damage from UV light using stem cells and their secretions show promise for skin repair without major risks.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Caspase-3 helps control cell growth and organ size by activating YAP.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Certain genes and pathways are linked to the production of finer and denser wool in Hetian sheep.